Speakers

   •  Giuseppe Battaglia
        University College of London, UK

Multiplexing and Multivalency in Nanomedicine Design

   •  Cynthia J. Burrows 
        University of Utah, USA

Beyond Watson and Crick:  Chemical Modifications in G-Quadruplexes Regulate Gene Expression

   •  Anne Imberty
        CNRS, FR

Lectins from Bacteria and Fungi: Therapeutical Targets and Research Tools

   •  Stephen Mann
        University of Bristol, UK

Synthetic Protobiology

   •  Modesto Orozco
        IRB Barcelona, ES

DNA Simulations from the Electron to the Chromosome... and Beyond

  •  Federico Gago
        University of Alcalá, ES

      The Biological Chemistry of Selected Elements from the Periodic Table

   •  Carmen Domene 
        University of Bath, UK

What Do We Know about Ion Conduction in Ion Channels?

   •  Margit Jeschke 
        Novartis, CH

Applying Established Concepts of Pharmaceutical Development to Industrialization of Cellular Cancer Immunotherapy

   •  Oscar Llorca 
       CNIO, ES

Mechanistic insights into the Function of HSP90 Co-chaperones by cryo-EM

   •  Oscar Millet
        CIC bioGUNE/ATLAS, ES

Repurposing Ciclopirox as a Pharmacological Chaperone for the Treatment of Congenital Erythropoietic Porphyria

   •  Javier Montenegro
        CIQUS-USC, ES

New Peptides Designs for Gene Delivery, Genetic Edition and the Preparation of Cytoskeleton Mimics

   •  Rolf Müller
        Helmholtz-HZI, DE

Discovery and Development of Antibiotics from (Myxo)bacterial Secondary Metabolites

   •  Christian Ottman
        Eindhoven University of Technology, NL

Stabilization of 14-3-3 Protein-Protein Interactions

   •  Teresa Pellegrino
        IIT, IT

Merging Magnetic Hyperthermia with other Anticancer Treatments for Tackling Cancer

   •  Mariana Gomes de Pinho
        ITQB, PT

Effects of Antibiotics on Cell Cycle Progression of Staphylococcus aureus

   • Torkild Visnes
        SINTEF Insdustry/ Karolinska Institutet, NO

SE Perturbation of mitochondrial genome stability with OGG1 inhibitors as a novel strategy to treat cancer

   •  Thomas R. Ward
        University of Basel, CH

Artificial Metalloenzymes: Challenges and Opportunities

   •  Gerard JP van Westen
        University of Leiden, NL

Combining Cheminformatics and Bioinformatics in Drug Discovery  - Lessons Learned and New Opportunities

   •  Jin Zhang 
        UCSD, USA

Illuminating the Biochemical Activity Architecture of the Cell